CIK: 0001869028 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 13, 2024
Total Value ($000): $8,317 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TCRX | TSCAN THERAPEUTICS INC | 630,000 | $3,673 | 44.2% | $9.27 | -50.6% | COM | 89854M101 |
| BRNS | BARINTHUS BIOTHERAPEUTICS PL | 642,204 | $2,370 | 28.5% | $16.78 | — | ADS | 91864C107 |
| HOWL | WEREWOLF THERAPEUTICS INC | 589,102 | $2,274 | 27.3% | $13.61 | -81.2% | COM | 95075A107 |